Heghine Khachatryan: An Elegant Example of Precision Thrombolysis – Targeting the Scaffold of Microvascular Thrombosis
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn about a recent article by Steven de Maat et al, published in Blood, adding:
“An elegant example of precision thrombolysis: targeting the scaffold of microvascular thrombosis.
In thrombotic thrombocytopenic purpura (TTP), severe ADAMTS13 deficiency permits the accumulation of ultra-large von Willebrand factor (VWF) multimers, promoting platelet-rich microthrombi and ischemic organ injury.
The study by de Maat and colleagues describes Microlyse – a fusion protein that combines a high-affinity VWF-targeting antibody fragment with the protease domain of urokinase-type plasminogen activator.
By directing plasminogen activation specifically toward platelet–VWF complexes, Microlyse is designed not merely to prevent further thrombus formation, but to actively dismantle established microvascular thrombi.
In experimental models, Microlyse degraded microthrombi seven times faster than caplacizumab at equimolar concentrations.
In an ADAMTS13-deficient mouse model of TTP, it also improved thrombocytopenia and markers of tissue injury without impairing hemostasis in a tail-bleeding model.
This work represents an important conceptual shift – from systemic fibrinolysis toward targeted, lesion-directed thrombolysis.
Although these remain preclinical findings and require validation in human studies, the approach may have broader relevance to VWF-driven thrombotic microangiopathies.
My sincere thanks to Coen Maas, one of the authors, for bringing this fascinating article to my attention.”
Title: Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis
Authors: Steven de Maat, Chantal C. Clark, Arjan D. Barendrecht, Simone Smits, Nadine D. van Kleef, Hinde El Otmani, Manon Waning, Marc van Moorsel, Michael Szardenings, Nicolas Delaroque, Kristof Vercruysse, Rolf T. Urbanus, Silvie Sebastian, Peter J. Lenting, Christoph Hagemeyer, Thomas Renné, Karen Vanhoorelbeke, Claudia Tersteeg, Coen Maas
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?